Welcome : Guest

Trevena, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Trevena, Inc., which is principally a Clinical Stage Biopharmaceutical Company. Illustrated with 18 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65595
Price: $900
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Chronic Pain......3
Table 1: No. of Population with Chronic Pain by Age in the US (2015) - Percentage Share Breakdown by Volume for 18 & over and 18 & Under......3
Table 2: No. of Population with Chronic Pain by Type in the US (2015) - Percentage Breakdown by Volume for Back Pain and Other Pain......4
Table 3: Spinal Cord Stimulation (SCS) for Chronic Pain by Category in the US (2015) - Percentage Share Breakdown by Volume for Back Pain alone, Leg & Back Pain, Leg Pain alone and Upper Extremity Pain......5
Table 4: Chronic Pain in Adults by Pain Type in the US (2015) - Percentage Share Breakdown by Volume for Knee Pain, Low Back Pain, Serve Headache or Migraine......6
Table 5: Spinal Cord Stimulation Systems for Chronic Pain (incl. back pain, leg pain and back/leg pain) Market Worldwide (2015) in US$ Million......7
Table 6: No. of People with Chronic Pain in the US (2015-2020) in Million......8
Central Nervous System (CNS) Drugs......9
Table 7: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......9
Table 8: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......10
Migraine Drugs......11
Table 9: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......11
Cardiology Therapeutics......12
Table 10: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......12
Table 11: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......13
Table 12: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......14
Antihypertensive Drugs......15
Table 13: Antihypertensive Drugs Market by Product in China (2105) - Percentage Share Breakdown by Value for Angiotensin II Receptor Blockers (ARBs), Beta Blocker, Calcium Channel Blocker and Others......15
Table 14: Hypertension Treatment Market by Segment in China (2015) - Percentage Share Breakdown by Value for Products to Regulate Blood Lipid Levels, and Products to Regulate Blood Sugar......16
Central Nervous System (CNS) Medicines......17
Table 15: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......17
Table 16: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......18
Cardiology Therapeutics......19
Table 17: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......19
Antihypertensive Drugs......20
Table 18: Market Shares of Leading Antihypertensive Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for AstraZeneca, Bayer AG, Novartis International AG, Pfizer, Inc., Sanofi-Aventis and Others......20